tiprankstipranks
Trending News
More News >
Duality Biotherapeutics, Inc. (HK:9606)
:9606
Hong Kong Market

Duality Biotherapeutics, Inc. (9606) Financial Statements

Compare
3 Followers

Duality Biotherapeutics, Inc. Financial Overview

Duality Biotherapeutics, Inc.'s market cap is currently HK$32.28B. The company's EPS TTM is HK$; its P/E ratio is ―; Duality Biotherapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 1.94B¥ 1.79B¥ 1.60M
Gross Profit¥ 784.67M¥ 1.36B¥ 1.60M
Operating Income¥ -188.99M¥ 781.36M¥ -368.58M
EBITDA¥ -1.01B¥ -197.07M¥ -385.22M
Net Income¥ -1.05B¥ -357.51M¥ -387.09M
Balance Sheet
Cash & Short-Term Investments¥ 1.39B¥ 1.13B¥ 375.97M
Total Assets¥ 2.09B¥ 1.50B¥ 463.74M
Total Debt¥ 5.29M¥ 5.32M¥ 4.67M
Net Debt¥ -1.20B¥ -1.13B¥ -371.31M
Total Liabilities¥ 4.11B¥ 2.62B¥ 1.23B
Stockholders' Equity¥ -2.02B¥ -1.12B¥ -769.12M
Cash Flow
Free Cash Flow¥ 254.60M¥ 780.43M¥ -321.67M
Operating Cash Flow¥ 285.78M¥ 816.34M¥ -299.47M
Investing Cash Flow¥ -211.15M¥ -78.55M¥ -22.20M
Financing Cash Flow¥ -7.62M¥ 10.82M¥ 451.46M
Currency in CNY

Duality Biotherapeutics, Inc. Earnings and Revenue History

Duality Biotherapeutics, Inc. Debt to Assets

Duality Biotherapeutics, Inc. Cash Flow

Duality Biotherapeutics, Inc. Forecast EPS vs Actual EPS